MCCORMICK FRANK
SEC insider (Form 3/4/5 filer). CIK 0001257809. Director at BridgeBio Pharma, Inc. (BBIO) and 1 other issuer. 16 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies MCCORMICK FRANK has filed insider reports for
- BridgeBio Pharma, Inc. (BBIO): Director
- BridgeBio Oncology Therapeutics, Inc. (BBOT): Director
MCCORMICK FRANK
CIK: 0001257809
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jun 22, 2026BBIO
BridgeBio Pharma, Inc.
AwardDirect4K shares- - Jun 16, 2026BBOT
BridgeBio Oncology Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31.7K shares- - Oct 29, 2025BBIO
BridgeBio Pharma, Inc.
SaleIndirect3.5K shares at avg. $67.52$236K - Oct 29, 2025BBIO
BridgeBio Pharma, Inc.
SaleIndirect8.6K shares at avg. $68.50$589K - Oct 29, 2025BBIO
BridgeBio Pharma, Inc.
SaleIndirect43.4K shares at avg. $69.24$3.0M - Oct 29, 2025BBIO
BridgeBio Pharma, Inc.
SaleIndirect111.8K shares at avg. $65.48$7.3M - Oct 29, 2025BBIO
BridgeBio Pharma, Inc.
SaleIndirect31.1K shares at avg. $66.20$2.1M - Oct 27, 2025BBIO
BridgeBio Pharma, Inc.
SaleIndirect1.6K shares at avg. $65.00$107K - Sep 5, 2025BBIO
BridgeBio Pharma, Inc.
SaleDirect74K shares at avg. $53.16$3.9M - Sep 5, 2025BBIO
BridgeBio Pharma, Inc.
ExerciseDirect74K shares at avg. $11.92$882K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  BBIO BridgeBio Pharma, Inc. | Award | 3,990 | - | $0 | Direct |
| Jun 16, 2026 |  BBOT BridgeBio Oncology Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,675 | - | - | Direct |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 3,497 | $67.52 | $236,130 | Indirect |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 8,598 | $68.50 | $588,985 | Indirect |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 43,393 | $69.24 | $3,004,349 | Indirect |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 111,755 | $65.48 | $7,317,315 | Indirect |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 31,116 | $66.20 | $2,059,749 | Indirect |
| Oct 27, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 1,641 | $65.00 | $106,665 | Indirect |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 74,000 | $53.16 | $3,933,544 | Direct |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | Exercise | 74,000 | $11.92 | $882,080 | Direct |
1-10 of 16 transactions